Sinus tachycardia is an accelerated cardiac rhythm that originates from the sinoatrial node, with a resting heart rate exceeding 100 beats per minute (bpm). It is a common physiological response to internal or external stimuli, such as physical exercise, stress, fever, or pain, but it may also reflect underlying pathological conditions.
This arrhythmia is characterized by a regular rhythm, with P waves of normal morphology followed by narrow QRS complexes, without signs of atrioventricular dissociation. Sinus tachycardia may be physiological, when it represents a normal compensatory response to increased metabolic demand, or pathological, when it is inappropriate relative to the body's needs.
It is important to distinguish sinus tachycardia from other supraventricular tachyarrhythmias, as treatment depends on the underlying cause. Although in most cases it is not dangerous, persistent or excessive sinus tachycardia can lead to bothersome symptoms and, in some cases, impair cardiac function.
Epidemiology
Sinus tachycardia is one of the most frequent arrhythmias, commonly observed both in the general population and among hospitalized patients. Its prevalence varies depending on the clinical context:
In healthy individuals, it is often transient and related to factors such as physical activity, stress, or the consumption of stimulants (caffeine, nicotine).
In hospitalized patients, sinus tachycardia is a frequent manifestation of conditions such as infections, anemia, heart failure, and hypovolemia.
Young women are particularly susceptible to inappropriate sinus tachycardia, a condition in which the sinoatrial node exhibits excessive autonomic activity without an apparent cause.
Although generally benign, sinus tachycardia can cause significant discomfort and, in some cases, contribute to the development of tachycardia-induced cardiomyopathy if not properly managed.
Etiology and Risk Factors
Sinus tachycardia can be classified into two main categories based on its etiology: physiological and pathological. In the physiological form, it represents a normal response of the organism to external or internal stimuli, whereas in the pathological form it is inappropriate or disproportionate to metabolic needs.
Physiological Causes
Sinus tachycardia is often an adaptive reaction to conditions that increase oxygen demand or stimulate the autonomic nervous system. The main physiological causes include:
Physical exercise: during exertion, increased metabolic demand leads to a higher heart rate to ensure adequate tissue perfusion.
Stress and anxiety: activation of the sympathetic nervous system and the release of catecholamines (adrenaline and noradrenaline) result in an accelerated heart rate.
Fever: for each degree above 37°C, the heart rate can increase by about 10 bpm.
Pain: nociceptive stimuli activate the sympathetic system, causing an increase in heart rate.
Hypovolemia and dehydration: a reduction in circulating volume stimulates catecholamine release to maintain cardiac output.
Pregnancy: hemodynamic and hormonal changes lead to a physiological increase in heart rate.
Pathological Causes
When sinus tachycardia occurs inappropriately or persists, it is often indicative of an underlying pathological condition. The main causes include:
Cardiovascular diseases:
Heart failure: decreased cardiac output induces a compensatory response with tachycardia.
Acute myocardial infarction: sympathetic activation and pain contribute to increased heart rate.
Pulmonary embolism: hypoxemia and sympathetic activation can trigger sinus tachycardia.
Endocrine and metabolic disorders:
Hyperthyroidism: excess thyroid hormones stimulate the sinoatrial node and increase catecholamine sensitivity.
Pheochromocytoma: excessive catecholamine release leads to persistent tachycardia.
Hypoglycemia: sympathetic activation in response to low blood glucose may induce tachycardia.
Infections and sepsis: fever, systemic inflammatory activation, and hypoxia contribute to increased heart rate.
Anemia: reduced oxygen-carrying capacity induces a compensatory increase in cardiac output.
Use of drugs and substances:
Stimulants such as caffeine, nicotine, cocaine, and amphetamines.
Withdrawal from beta-blockers or sedatives (benzodiazepines, opioids).
Inappropriate Sinus Tachycardia
A particular form is inappropriate sinus tachycardia (IST), characterized by a chronic and disproportionate increase in heart rate at rest and during minimal exertion, without an identifiable cause. This condition is often associated with autonomic dysfunction, featuring excessive sympathetic activation or reduced parasympathetic activity. IST primarily affects young women and can cause debilitating symptoms such as palpitations, fatigue, and orthostatic intolerance.
Pathophysiology
Sinus tachycardia results from an increased firing rate of the sinoatrial node, the heart’s primary pacemaker. This phenomenon is regulated by a complex interaction between the autonomic nervous system, baroreceptor reflexes, and endocrine mediators.
Mechanisms Regulating Heart Rate
The sinoatrial node is under the control of two autonomic nervous system components:
Sympathetic nervous system: activation of β1-adrenergic receptors by catecholamines (adrenaline and noradrenaline) increases the firing rate of the sinoatrial node and atrioventricular conduction.
Parasympathetic nervous system: the vagus nerve exerts an inhibitory effect on heart rate via muscarinic M2 receptors, reducing the spontaneous depolarization of sinoatrial node cells.
Under normal conditions, the balance between these two systems keeps the heart rate within a physiological range. However, various stimuli can disrupt this regulation, causing an increase in heart rate.
Role of Catecholamines
Catecholamines play a crucial role in sinus tachycardia. In response to physical or emotional stress, the sympathetic nervous system releases adrenaline and noradrenaline, which:
Increase the rate of depolarization of pacemaker cells.
Shorten the refractory period of the sinoatrial node.
Enhance myocardial contractility and oxygen consumption.
These effects enable a rapid response to increased energy demands, but may become pathological when tachycardia is disproportionate or persistent.
Hemodynamic Adaptations
Sinus tachycardia affects cardiovascular dynamics in several ways:
Increased cardiac output: initially, tachycardia improves tissue perfusion by increasing the volume of blood pumped by the heart.
Reduced diastolic filling time: as heart rate increases, the diastolic phase shortens, reducing ventricular filling and, consequently, cardiac output.
Decreased coronary blood supply: the reduction in diastole limits coronary artery blood flow, with potential for myocardial ischemia in patients with pre-existing cardiac disease.
Sinus Tachycardia and Autonomic Dysfunction
In some patients, sinus tachycardia may result from dysregulation of the autonomic nervous system. This is seen in conditions such as:
Inappropriate sinus tachycardia: characterized by sympathetic overactivity or reduced vagal tone.
Postural orthostatic tachycardia syndrome (POTS): an abnormal response to standing with excessive heart rate increase.
These disorders highlight the key role of autonomic regulation in the genesis of pathological sinus tachycardia.
Clinical Presentation
The clinical presentation of sinus tachycardia varies according to its cause, speed of onset, and the presence of underlying diseases. While in many cases it is asymptomatic or well tolerated, in others it can produce significant symptoms affecting the patient's quality of life.
Medical History
A thorough medical history is crucial to identify the cause of sinus tachycardia. Key elements to assess include:
Onset and duration: paroxysmal tachycardia may suggest an autonomic or functional cause.
Triggering factors: stress, anxiety, fever, drugs, or physical exertion.
Associated symptoms: palpitations, dyspnea, fatigue, dizziness, or orthostatic intolerance.
Comorbidities: hyperthyroidism, anemia, cardiac diseases, or dysautonomia.
Use of drugs or substances: caffeine, nicotine, stimulants, or withdrawal from beta-blockers.
Symptoms
The symptoms of sinus tachycardia depend on its cause and the degree of individual tolerance. The most common include:
Palpitations: subjective awareness of a rapid heartbeat, often described as a “pounding heart” or irregular beats.
Dyspnea: shortness of breath, especially in patients with left ventricular dysfunction.
Dizziness and near-syncope: related to reduced cerebral perfusion in cases of persistent tachycardia.
Orthostatic intolerance: present in conditions such as POTS, with marked tachycardia upon standing.
Fatigue and asthenia: common in patients with inappropriate sinus tachycardia or associated with chronic diseases.
Chest pain: in patients with reduced coronary reserve, due to decreased diastolic coronary blood flow.
Sweating and anxiety: especially in tachycardias related to sympathetic overactivity.
Physical Examination
On physical examination, findings may indicate sinus tachycardia and its underlying causes:
Resting heart rate above 100 bpm, with regular rhythm.
Normal or reduced blood pressure, depending on the cause (hypovolemia, shock, dysautonomia).
Signs of hyperthyroidism: warm skin, fine tremors, exophthalmos.
Signs of dehydration or anemia: dry mucous membranes, orthostatic hypotension, pallor.
The pulse is typically rapid and regular, without the irregularities seen in other tachyarrhythmias such as atrial fibrillation.
Diagnosis and Investigations
The diagnosis of sinus tachycardia is based on the correlation between clinical data and instrumental exams. The goal is to confirm the sinus origin of the tachycardia and rule out secondary causes or more complex arrhythmias.
Electrocardiogram (ECG)
The ECG is the first examination to be performed and allows confirmation of the sinus nature of the tachycardia. Diagnostic criteria include:
Heart rate >100 bpm (usually between 100-160 bpm, rarely higher).
P waves of normal morphology, positive in leads II, III, and aVF and preceding every QRS complex.
Constant PR interval, without signs of atrioventricular dissociation.
Narrow QRS (<120 ms), without evidence of preexcitation or bundle branch block.
Absence of ectopic beats or irregularities suggestive of other supraventricular tachyarrhythmias.
24-hour Holter Monitoring
In cases of episodic or persistent sinus tachycardia, Holter ECG monitoring allows assessment of heart rate variability over 24 hours and its relationship with physical activity, rest, and autonomic stimuli. It is useful in distinguishing inappropriate sinus tachycardia from other tachyarrhythmias.
Autonomic Tests
In suspected inappropriate sinus tachycardia or postural orthostatic tachycardia syndrome (POTS), specific tests can be performed to assess autonomic regulation:
Exercise test: evaluates the chronotropic response to physical activity.
Active standing test: observes the heart rate response when moving from supine to upright position.
Tilt table test: useful in suspected POTS, documents a marked and persistent increase in heart rate in the absence of hypotension.
Laboratory Tests
Blood tests are essential to identify secondary causes of sinus tachycardia:
Complete blood count: to rule out anemia.
Thyroid hormones (TSH, FT3, FT4): to assess for hyperthyroidism.
Blood glucose and glucose tolerance test: to exclude reactive hypoglycemia.
D-dimer: if pulmonary embolism is suspected.
Urinary catecholamines: if pheochromocytoma is suspected.
Differential Diagnosis
It is essential to distinguish sinus tachycardia from other supraventricular tachyarrhythmias that may mimic it:
Ectopic atrial tachycardia: P waves of abnormal morphology.
Atrioventricular nodal reentrant tachycardia: sudden onset and termination, absence of visible P waves.
Atrioventricular reentrant tachycardia: narrow QRS with retrograde P waves.
Atrial fibrillation or atrial flutter: irregular rhythm or characteristic F waves.
Treatment and Management
The therapeutic strategy for sinus tachycardia depends on its cause and the presence of symptoms. In most cases, no specific treatment is required, but it is essential to identify and correct underlying factors.
General Approach
The first step in managing sinus tachycardia is to determine whether it is:
Physiological: adaptive response to an external stimulus (exercise, fever, stress) → does not require treatment, but only control of the triggering factor.
Pathological: secondary to a medical condition (hyperthyroidism, anemia, hypovolemia, infections) → targeted treatment of the underlying disease.
Inappropriate: persistent sinus tachycardia without an evident cause → pharmacological and/or non-pharmacological approach.
Non-Pharmacological Measures
In patients with inappropriate or symptomatic sinus tachycardia, certain behavioral strategies may be useful:
Lifestyle modification: avoidance of stress, caffeine, nicotine, and alcohol.
Adequate hydration: useful in patients with dysautonomia and relative hypovolemia.
Regular aerobic exercise: may improve autonomic control of heart rhythm.
Vagal maneuvers: in cases of transient symptomatic sinus tachycardia, carotid sinus massage may reduce heart rate.
Pharmacological Therapy
Pharmacological treatment is indicated only in symptomatic cases or in patients with persistent inappropriate sinus tachycardia.
Beta-blockers (propranolol, metoprolol, bisoprolol): reduce the effect of catecholamines on the sinoatrial node, lowering heart rate.
Non-dihydropyridine calcium channel blockers (verapamil, diltiazem): useful in patients who do not tolerate beta-blockers.
Ivabradine: inhibits the If channel of the sinoatrial node, reducing heart rate without affecting blood pressure or myocardial contractility.
Anti-anxiety drugs (benzodiazepines, serotonin reuptake inhibitors): in cases of tachycardia related to sympathetic hyperactivation due to anxiety.
Invasive Options
In extreme cases refractory to medical therapy, invasive treatment may be considered:
Catheter ablation: reserved for patients with disabling inappropriate sinus tachycardia, involves modulation of the sinoatrial node discharge.
Neuromodulation: in experimental studies, vagal stimulation or cardiac sympathetic denervation have been used to reduce refractory sinus tachycardia.
Prognosis and Complications
The prognosis of sinus tachycardia depends on its etiology and the presence of underlying diseases. In most cases, it is a benign condition, with a good response to correction of triggers or pharmacological therapy.
Clinical Course
Physiological sinus tachycardia: self-limited and reversible with resolution of the triggering cause.
Inappropriate sinus tachycardia: may be chronic and symptomatic, but rarely progresses to severe complications.
Secondary sinus tachycardia: prognosis depends on the underlying disease (e.g., heart failure, hyperthyroidism, severe anemia).
Complications
Although sinus tachycardia is generally benign, a persistently elevated heart rate can, in some cases, lead to complications:
Tachycardia-induced cardiomyopathy: chronic, sustained sinus tachycardia may cause myocardial remodeling with left ventricular dysfunction.
Reduced exercise tolerance: in patients with inappropriate sinus tachycardia, high heart rate can limit exercise capacity.
Dysautonomia and orthostatic intolerance: associated with postural orthostatic tachycardia syndrome (POTS) in patients with autonomic dysfunction.
Myocardial ischemia: in patients with pre-existing coronary artery disease, sinus tachycardia may reduce coronary flow and worsen angina.
Follow-up
In patients with inappropriate or secondary sinus tachycardia due to chronic diseases, regular monitoring is important to assess the evolution of heart rate and response to therapy. Serial echocardiography may be useful in patients with persistent tachycardia to rule out signs of tachycardia-induced cardiomyopathy.
Conclusion
Sinus tachycardia is a heart rhythm disturbance frequently encountered in clinical practice. Although in most cases it is a physiological response to external stimuli, it is important to recognize pathological and inappropriately elevated forms, which may require specific treatment.
Diagnosis is based on ECG and identification of the underlying cause, while treatment is aimed at resolving the triggering factors. In symptomatic cases, beta-blockers, calcium channel blockers, or ivabradine may be valid therapeutic options.
The prognosis is generally favorable, but long-term monitoring is recommended in patients with persistent sinus tachycardia to prevent possible complications.
References
Fletcher GF, et al. Exercise and the heart: Clinical implications and management strategies. Circulation. 2013;127(15):1871-1876.
Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier; 2018.
Sheldon RS, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-e63.
Shibata S, Fu Q, Bivens TB, et al. Physiological basis of excessive heart rate response to exercise in postural tachycardia syndrome. J Am Coll Cardiol. 2013;61(19):2049-2059.
Gopinathannair R, Etheridge SP, Marchlinski FE, et al. Arrhythmias in the athlete: Mechanisms and management. J Am Coll Cardiol. 2021;78(16):1601-1613.
Joseph A, Wan E, Zaman S. Postural orthostatic tachycardia syndrome (POTS): Pathophysiology, diagnosis, and management. Heart. 2019;105(8):633-638.
Brignole M, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal. 2018;39(21):1883-1948.
Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal. 2015;36(42):2921-2964.
Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Clinical presentation and management of patients with postural orthostatic tachycardia syndrome. Expert Rev Cardiovasc Ther. 2009;7(2):165-169.
